alendronate has been researched along with Thalassemia in 1 studies
alendronic acid : A 1,1-bis(phosphonic acid) that is methanebis(phosphonic acid) in which the two methylene hydrogens are replaced by hydroxy and 3-aminopropyl groups.
Thalassemia: A group of hereditary hemolytic anemias in which there is decreased synthesis of one or more hemoglobin polypeptide chains. There are several genetic types with clinical pictures ranging from barely detectable hematologic abnormality to severe and fatal anemia.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zekavat, OR | 1 |
| Bordbar, M | 1 |
| Haghpanah, S | 1 |
| Saki, F | 1 |
| Bazrafshan, A | 1 |
| Bozorgi, H | 1 |
1 trial available for alendronate and Thalassemia
| Article | Year |
|---|---|
Comparative effectiveness of alendronate and zoledronic acid on bone mass improvement in transfusion-dependent thalassemia patients.
Topics: Absorptiometry, Photon; Adolescent; Adult; Alendronate; Blood Transfusion; Bone and Bones; Bone Dens | 2019 |